Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Novo ends all cell therapy R&D, lets go of staff
Novo is looking for partners to further develop its cell therapy programs, a spokesperson told Fierce Biotech.
Gabrielle Masson
Oct 10, 2025 3:30pm
J&J eyes takeover of immunology partner Protagonist: WSJ
Oct 10, 2025 2:30pm
Fierce Healthcare
Government shutdown updates: Reductions in force begin at HHS
Oct 10, 2025 2:05pm
MIT rejects Trump deal tying research money to certain demands
Oct 10, 2025 1:12pm
Fierce Biotech Layoff Tracker 2025: Ascidian, Novo & more
Oct 10, 2025 1:00pm
Cabaletta’s CAR-T wipes out B cells with no preconditioning
Oct 10, 2025 11:11am
More News
Not a straight line: Biotech finds resilience in tumultuous year
Oct 10, 2025 10:44am
AstraZeneca: Building a transparent pipeline from the ground up
Oct 10, 2025 9:52am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
Former CBER chief Peter Marks leaps to Lilly—Chutes & Ladders
Oct 10, 2025 8:30am
See more stories